SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 145 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $529,162 | -47.5% | 300,660 | -6.4% | 0.00% | -100.0% |
| Q4 2022 | $1,008,756 | -29.7% | 321,260 | +9.7% | 0.00% | 0.0% |
| Q3 2022 | $1,435,000 | +18.4% | 292,760 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,212,000 | -28.7% | 292,760 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,701,000 | -16.0% | 292,760 | +8.4% | 0.00% | 0.0% |
| Q4 2021 | $2,026,000 | -16.8% | 270,160 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $2,434,000 | -24.2% | 270,160 | +0.7% | 0.00% | 0.0% |
| Q2 2021 | $3,212,000 | -6.7% | 268,360 | -2.3% | 0.00% | 0.0% |
| Q1 2021 | $3,441,000 | -18.7% | 274,660 | +1.2% | 0.00% | -33.3% |
| Q4 2020 | $4,235,000 | +65.2% | 271,360 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $2,564,000 | +10.6% | 271,360 | +4.9% | 0.00% | 0.0% |
| Q2 2020 | $2,318,000 | +61.9% | 258,760 | +15.1% | 0.00% | 0.0% |
| Q1 2020 | $1,432,000 | -22.8% | 224,860 | +1.5% | 0.00% | 0.0% |
| Q4 2019 | $1,854,000 | -5.3% | 221,460 | +2.4% | 0.00% | 0.0% |
| Q3 2019 | $1,958,000 | -13.6% | 216,360 | +2.9% | 0.00% | 0.0% |
| Q2 2019 | $2,266,000 | +27.7% | 210,360 | +13.1% | 0.00% | 0.0% |
| Q1 2019 | $1,775,000 | -14.0% | 186,060 | +3.5% | 0.00% | -33.3% |
| Q4 2018 | $2,064,000 | -31.2% | 179,760 | +1.5% | 0.00% | 0.0% |
| Q3 2018 | $3,001,000 | +22.0% | 177,060 | +2.3% | 0.00% | 0.0% |
| Q2 2018 | $2,459,000 | -11.0% | 173,160 | +19.1% | 0.00% | 0.0% |
| Q1 2018 | $2,762,000 | +18.2% | 145,360 | +2.0% | 0.00% | 0.0% |
| Q4 2017 | $2,336,000 | +13.6% | 142,460 | +3.9% | 0.00% | +50.0% |
| Q3 2017 | $2,056,000 | +62.8% | 137,060 | -4.5% | 0.00% | +100.0% |
| Q2 2017 | $1,263,000 | +113.7% | 143,560 | +26.4% | 0.00% | 0.0% |
| Q1 2017 | $591,000 | +70.8% | 113,560 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $346,000 | -34.2% | 113,560 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $526,000 | -20.1% | 113,560 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $658,000 | -0.8% | 113,560 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $663,000 | -21.2% | 113,560 | +23.2% | 0.00% | -50.0% |
| Q4 2015 | $841,000 | +61.7% | 92,160 | 0.0% | 0.00% | +100.0% |
| Q3 2015 | $520,000 | -40.7% | 92,160 | +16.6% | 0.00% | -50.0% |
| Q2 2015 | $877,000 | -29.3% | 79,060 | 0.0% | 0.00% | -33.3% |
| Q1 2015 | $1,240,000 | +5.8% | 79,060 | +2.6% | 0.00% | -25.0% |
| Q4 2014 | $1,172,000 | +45.4% | 77,060 | +3.1% | 0.00% | +33.3% |
| Q3 2014 | $806,000 | -29.4% | 74,760 | 0.0% | 0.00% | -25.0% |
| Q2 2014 | $1,142,000 | -15.5% | 74,760 | 0.0% | 0.00% | -20.0% |
| Q1 2014 | $1,352,000 | +75.6% | 74,760 | +34.9% | 0.01% | +66.7% |
| Q4 2013 | $770,000 | +32.5% | 55,400 | 0.0% | 0.00% | +50.0% |
| Q3 2013 | $581,000 | +42.4% | 55,400 | +5.9% | 0.00% | 0.0% |
| Q2 2013 | $408,000 | – | 52,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 968,505 | $12,135,000 | 1.23% |
| Golden State Equity Partners | 126,608 | $1,586,000 | 0.90% |
| McGuire Investment Group, LLC | 272,801 | $3,418,000 | 0.72% |
| Lombard Odier Asset Management (Switzerland) SA | 848,429 | $10,631,000 | 0.70% |
| Rhenman & Partners Asset Management AB | 765,000 | $9,585,000 | 0.67% |
| EMC Capital Management | 72,061 | $903,000 | 0.64% |
| WASATCH ADVISORS LP | 10,328,423 | $129,415,000 | 0.58% |
| Ceeto Capital Group, LLC | 74,000 | $927,000 | 0.45% |
| Fort Sheridan Advisors LLC | 75,945 | $952,000 | 0.38% |
| Vanguard Capital Wealth Advisors | 34,580 | $388,679,000 | 0.33% |